Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Natesto on demand for hypogonadal men with ED on daily Tadalafil
NCT05484167Phase 4Withdrawn
- Sponsor
- University of Utah
- Start
- Jan 2023
- Primary completion
- Jan 2024
- Countries
- 1
01
Overview
A Phase 4 trial of natesto in erectile dysfunction (ED), Hypogonadism, sponsored by University of Utah. Planned start Jan 2023; status: withdrawn.
02
Drugs
natesto
03
Conditions
erectile dysfunction (ED)Hypogonadism
Beyond the preview
Go deeper on NCT05484167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05484167.